Comparison Liminatus Pharma (LIMN) with Competitors
Liminatus Pharma (LIMN) industry is Biotechnology.
Debt-to-Equity
LIMN-1087.89%
Industry28.27%
Upside-1116.16%
P/E
LIMN-0.27
Industry-20.52
Upside+2024.43%
Liminatus Pharma (LIMN) industry is Biotechnology.